Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Regression Models and Life-Tables

Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793

Regression Models and Life-Tables

Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463

Parkinson Disease in Twins

Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 876

Epidemiology of parkinson’s disease

Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640

Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii

Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 524

Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study

White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437

TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM

Yano, K., REED, D. M., & McGee, D. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113787 · Cited by 370

Worldwide Occurrence of Parkinson's Disease: An Updated Review

Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332

Parkinson disease is a TH17 dominant autoimmune disorder against accumulated alpha-synucleinPreprint

Hu, W.-C. (2011) · Nature Precedings · doi:10.1038/npre.2011.6176.1 · Cited by 9

Association of a Healthy Lifestyle with Risk of Parkinson’s Disease and Genetic Predisposition

Jiang, Q., Lin, J., Wei, Q., Li, C., Ou, R., Zhang, L., Hou, Y., Yang, T., Xiao, Y., Wang, S., et al. (2025) · Neuroepidemiology · doi:10.1159/000547706 · Cited by 2

Global burden of early-onset Parkinson’s disease, 1990–2021: results from the Global Burden of Disease Study 2021

Ji, Q., Chen, Z., Ma, Y., Guan, Q., Chu, F., Chen, L., Ji, J., Sun, M., Ren, G., Huang, T., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-335535 · Cited by 3

Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson’s disease

Mohamed, Y. A., Nadeem, A. A. A., Ismail, L. M., Ghallab, Y. K., Ouédraogo, R. J., Elhelw, J., Ahmed, M., & Tharwat, E. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.012 · Cited by 2

Construction of an aligned monolingual treebank for studying semantic similarity

Marsi, E., & Krahmer, E. (2013) · Language Resources and Evaluation · doi:10.1007/s10579-013-9252-1 · Cited by 2

Evaluation of frequency of depression in a subset of population with idiopathic parkinsonism in a tertiary care hospital

Ali, A., Mahar, S. H., Kumar, D. J. S., Fatima, M., Abbas, S., Iltaf, S., & Asghar, M. S. (2021) · Romanian Journal of Neurology · doi:10.37897/rjn.2021.3.17 · Cited by 2

Yerbamate Tea Consumption: A Protective Factor in Parkinson Disease

Sáenz‐Farret, M., Salinas-Martı́nez, A. M., Zúñiga‐Ramírez, C., Amorín-Costábile, I., Maiola, R., Mejía-Rojas, K. K., Galeano, M. S., Velázquez, C., Ruiz, G., & Micheli, F. E. (2022) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000513 · Cited by 2

Parkinson’s Disease: A Comprehensive Overview of the Disease

Khatib, A. J. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109437 · Cited by 2

Das Exposom im Fokus präventiver Maßnahmen für die Alzheimer- und Parkinson-Erkrankung

Schäffer, E., & Piel, J. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01538-9 · Cited by 2

Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries

Khalil, H. W., Shraim, M., Jaradat, B., IBRAHIM, R. H. A., Kamel, W. A., Khan, S., Aldughmi, M., Amer, H. M. A., Al‐Qassabi, A., Al‐Sharman, A., et al. (2025) · International Journal of Public Health · doi:10.3389/ijph.2025.1608016 · Cited by 2

Purines as Transmitter Molecules: Electrophysiological Studies on Purinergic Signalling in Different Cell Systems

Coppi, E. (2009) · Premio Tesi dottorato/Premio Tesi di dottorato · doi:10.36253/978-88-8453-905-2 · Cited by 2

Does caffeine protect against Parkinson’s disease? A preliminary study

Brown, I. (2002) · Nutrition & Food Science · doi:10.1108/00346650210454217 · Cited by 2

Simulateous Determination for the Contents of Caffeine and Chlorogenic Acid in Coffee Beans

Shin, J. H., & Ahn, Y. G. (2013) · The Korean Journal of Community Living Science · doi:10.7856/kjcls.2013.24.1.5 · Cited by 2

Neurologic diseases, epidemiology, and public health

Kukull, W. A., & Bowen, J. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199218707.003.0067 · Cited by 2

Caffeine and Neuroprotection in Parkinson’s Disease

Rodrigues, F. B., Caldeira, D., Ferreira, J. J., & Costa, J. G. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-20273-0_12 · Cited by 2

Polycyclic Aromatic Hydrocarbons formed during Roasting Process in Arabica Coffee Beans

Gawri, S., & Singh, S. (2013) · Cited by 2

Neuroepidemiology: Fundamental Considerations

Nelson, L. M., Tanner, C. M., Eeden, S. K. V. D., & McGuire, V. M. (2004) · doi:10.1093/acprof:oso/9780195133790.003.01 · Cited by 2

Gesundheitsfördernde Wirkung von Koffein

Beiglböck, W. (2016) · Springer eBooks · doi:10.1007/978-3-662-49564-3_5 · Cited by 2

Adenosine Receptor Biology in the Central Nervous System

Freissmuth, M., & Klotz, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803724-9.00001-6 · Cited by 3

Coffee: Grounds for Concern?

Weisse, A. B. (2015) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2015.11929209 · Cited by 2

Coffee Is More Than Caffeine

Cossenza, M. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0014 · Cited by 2

Caffeine

Menezes, F. P., & da Silva, R. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00022-6 · Cited by 2

Epidemiology

Lo, R. Y., & Tanner, C. M. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.002 · Cited by 2

The Psychology of Supplementation in Sport and Exercise: Motivational Antecedents and Biobehavioral Outcomes

Arent, S. M., & Lutz, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-18230-8_2 · Cited by 2

Kawa i jej prozdrowotne właściwości

Baran, J., & Kubit, P. (2023) · HERBALISM · doi:10.12775/herb.2021.002 · Cited by 2

Coffee, Granulocyte Colony-Stimulating Factor (G-CSF), and Neurodegenerative Diseases

Cao, C., Moore, T. R., Chu, L., & Xu, Q. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409517-5.00048-6 · Cited by 2

Preliminary in vitro evaluation of neuroprotective and monoamine oxidase type B inhibitory effects of newly synthesized 8-aminocaffeines

Kondeva-Burdina, M., Georgieva, M., Kasabova-Angelova, A., Tzankova, V., & Zlatkov, A. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.250573 · Cited by 2

Does Caffeine Consumption Affect the Symptoms of Parkinson’s Disease? A Systematic Review of Clinical Trials

Reyhanifard, A., Sanaie, S., Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, M., Rahnemayan, S., Fathalizadeh, A., Mahmoodpoor, A., & Faramarzi, E. (2021) · Archives of Neuroscience · doi:10.5812/ans.115878 · Cited by 3

Coffee and Risk of Type 2 Diabetes

Bidel, S., & Tuomilehto, J. (2007) · Työväentutkimus Vuosikirja · Cited by 2

Olfactory Dysfunction

Duda, J. E., & Stern, M. B. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch28 · Cited by 2

Caffeine intake and the plasma proteome

Tian, O., Josse, A. R., & El‐Sohemy, A. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.1080.3 · Cited by 1

Caffeine’s Effects on the Human Stress Axis

Lovallo, W. R., & Al’Absi, M. (2004) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203618851.ch8 · Cited by 1

Anticholinesterase and Anticalaleptic Effects of Instant Coffee

Köhn, D., Molska, G. R., de Paula-Freire, L. I. G., Negri, G., Carlini, E. A., & Mendes, F. R. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2022.0148 · Cited by 1

Tea and coffee powders

Huang, M., & Zhang, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-98820-9.00003-x · Cited by 1

Studying Vibratory Patterns of Vocal Folds and Their Impairments in Parkinson’s Disease: A Theoretical Approach

Indu, R., & Dimri, S. C. (2024) · International Journal of Computing and Digital Systems · doi:10.12785/ijcds/150182 · Cited by 1

Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons

Ngo, H. K. C., Srivastava, A., Le, H., Ayer, S. J., Crotty, G. F., Schwarzschild, M. A., & Bakshi, R. (2025) · BMC Neuroscience · doi:10.1186/s12868-025-00939-7 · Cited by 1

Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study

Tsaktanis, T., Gessner, A., Pfeuffer, S., Farrenkopf, D., Naumann, U. J., Fröhlich, K., Sembill, J. A., Fromm, M. F., Schwab, S., Rothhammer, V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31107-w · Cited by 1

Oxidative stress and inflammation in neurodegenerative disorders

Jomová, K., Alomar, S. Y., Valko, R., Nepovimová, E., Kuča, K., & Valko, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04518-5 · Cited by 1

Sleep, Adenosine and Caffeine as Tools for The Early Diagnosis of Parkinson Disease

Salín-Pascual, R. J. (2012) · The Open Sleep Journal · doi:10.2174/1874620901205010059 · Cited by 1

Coffee and the Risk of Dementia and Cognitive Impairment

Gelber, R. P., & White, L. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00082-3 · Cited by 1

Caffeine and the Older Person

Wynne, H. (2008) · Modern nutrition · doi:10.1201/9781420059724.ch10 · Cited by 1

Effect of caffeine on Alzheimer’s molecular factors in correlation with involved cell communication systems in developing zebrafish Danio rerio

Abdelkader, T. S., Chang, S., Lee, J.-M., Song, J., Oh, H., & Park, J. (2015) · Journal of Laboratory Medicine · doi:10.1515/labmed-2015-0028 · Cited by 1

Overview of Biologically Based Therapies in Rehabilitation

Gerik, S. M., & Maypole, J. (2008) · Elsevier eBooks · doi:10.1016/b978-072160111-3.50016-6 · Cited by 2

Investigation of Nonmotor Symptoms in First-Degree Relatives of Patients with Different Clinical Types of Parkinson’s Disease

Liu, J.-B., Leng, J., Wang, Y.-G., Zhang, Y., Tang, T., Tao, L., Zhang, X., & Liu, C. (2019) · Parkinson s Disease · doi:10.1155/2019/1654161 · Cited by 1

Effect of catechin and commercial preparation of green tea essence on the pharmacokinetics of l ‐dopa in rabbits

Lin, S., Tai, L., Huang, Y., Uang, Y., Ho, Y., Hsu, K., & Wang, L. (2021) · Biomedical Chromatography · doi:10.1002/bmc.5227 · Cited by 1

Chalcone‐inspired rA1/A2A adenosine receptor ligands: Ring closure as an alternative to a reactive substructure

Matthee, C., Terre’Blanche, G., van Rensburg, H. D. J., Aucamp, J., & Legoabe, L. J. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13999 · Cited by 1

Caffeine, chocolate, and adenosine antagonism in Parkinson’s disease

Reichmann, H. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.24 · Cited by 1

ALSUntangled #70: caffeine

Hatch, J., Barkhaus, P. E., Barnes, B., Beauchamp, M. T., Benatar, M. G., Bertorini, T. E., Bowser, R. P., Bromberg, M. B., Brown, A. D., Cadavid, J. M., et al. (2023) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2023.2220742 · Cited by 1

Parkinson's Disease

Echchakery, M., Guennouni, M., Amane, M., Omari, M., Baz, S. E., Achbani, A., Draoui, A., Aimrane, A., Otmani, I. E., Rokni, T., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch008 · Cited by 3

Precision Nutrition in Aging and Brain Health

Chen, S. T., & Small, G. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00017-1 · Cited by 1

Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists

Simola, N., Pinna, A., Frau, L., & Morelli, M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_103 · Cited by 1

Nutritional Supplementation, Diet, and Genetics and Their Impact on Parkinson’s Disease (PD), a Review of Studies

Petrosino, S. P. (2014) · Journal of Nutritional Health & Food Engineering · doi:10.15406/jnhfe.2014.01.00038 · Cited by 1

Imaging Studies with A2A Receptor Antagonists

Tavares, A., Barret, O., Seibyl, J. P., & Tamagnan, G. D. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-20273-0_11 · Cited by 1

Gut Microbiota in Brain Development and Disorders of the CNS: Therapeutic Strategies Involving Dietary Modification, Pro- and Prebiotic Intervention, and Fecal Microbiota Transplantation (FMT) Therapy

Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00012-0 · Cited by 1

Molecular Aspects of Hippocampal Aging

Temido‐Ferreira, M., & Lopes, L. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_3 · Cited by 1

Chemopreventive Molecules of Coffee and Beneficial Metabolic Effects.

Vassallo, A., Bonomo, M. G., Finelli, F. G., Salzano, S., Catalano, A. A., Sinicopi, Maia, S. I. C., Capasso, A., & Saturnino, S. (2021) · CINECA IRIS Institutional Research Information System (University of Basilicata) · Cited by 1

Coffea arabica

(2007) · Humana Press eBooks · doi:10.1007/978-1-59259-887-8_4 · Cited by 1

Coffea arabica

Lim, T. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-5653-3_32 · Cited by 1

Mechanisms of fatigue during prolonged exercise in the heat

Bridge, M. (2002) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 1

Does a latte a day keep the hepatologist away?

Fix, O. K. (2007) · Hepatology · doi:10.1002/hep.22153 · Cited by 1

The Putative Neuroprotective Effects of Caffeine

James, M. J. E., Chen, P. X., Morelli, M., Postuma, R., & Schwarzschild, M. A. (2011) · Journal of Caffeine Research · doi:10.1089/jcr.2011.1207 · Cited by 1

Prevention of Experimental Cataract Induced by UVR

Kronschläger, M. (2014) · Uppsala University Publications (Uppsala University) · Cited by 1

Prevalência de inadequação da ingestão de nutrientes entre adolescentes do município de São Paulo

Verly, E. (2009) · doi:10.11606/d.6.2009.tde-08092009-084842 · Cited by 1

PARKINSON'S DISEASE

Suchowersky, O., & Furtado, S. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293565.71963.bd · Cited by 1

Amphetamine and Other Psychostimulants

Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50008-8 · Cited by 1

Coffee, smoking and aspirin are associated with age at onset and clinical severity in idiopathic Parkinson’s diseasePreprint

Gabbert, C., König, I. R., Lüth, T., Kolms, B., Kasten, M., Vollstedt, E., Balck, A., Study, F. I., Grünewald, A., Klein, C., et al. (2021) · medRxiv · doi:10.1101/2021.11.08.21265971 · Cited by 1

Management of Parkinson??s Disease

Ibbotson, T., & Goa, K. L. (2002) · Disease Management & Health Outcomes · doi:10.2165/00115677-200210100-00005 · Cited by 1

Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional

Cardoso, E. F. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2008.tde-24072008-145234 · Cited by 1

Management of Parkinson's disease

Hermanowicz, N. S. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.12.1060

The study of caffeine on reaction time and error rate among college students

Hickey, S. (2014) · eSource (Dublin Business School)

Affinity of dihydropyrimidone analogues for adenosine A1 and A2A receptors

Katsidzira, R. M. (2014)

Caffeine Reduces Risk of Parkinson’s Disease

Harnprasertpongse, N., & Sangdee, C. (2014) · Journal of Basic and Applied Pharmacology

An analysis of the effects of various compounds on alcohol and high-fat-diet-induced steatosis in rats and mice

Nolan, B. (2009) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3ks6rs0

Morbus Parkinson — Pathophysiologie, Diagnose und medikamentöse Therapie

Wöhrle, J. C., & Hennerici, M. G. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1956-5_10 · Cited by 1

Genes Involved in Parkinson's Disease - Focus on Mitochondrial and Detoxifying Enzymes

Anvret, A. (2011) · Figshare

Neurotoxins and Neurodegenerative Disorders in Japanese-American Men Living in Hawaii

Ross, G. W. (2005) · doi:10.21236/ada435080

Dietary Factors in Geriatric Neurology

Gu, Y., & Scarmeas, N. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch27

Natural Health Products in Parkinson Disease

Sadowski, C. A., & Heschuk, S. (2010) · Health care and disease management · doi:10.1002/9783527629480.ch6

Influence of Neurological Medication on Nutritional Status

Aloupis, M., & Golaszewski, A. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-362-6_17

Synucleins in the midbrain dopaminergic system : the role in health and disease

Connor‐Robson, N. (2013) · ORCA Online Research @Cardiff (Cardiff University)

Ensuring good nutritional status in patients with Parkinson's disease: challenges and solutions

Baroni, L., & Zuliani, C. (2014) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s49186

Morbo di Parkinson idiopatico: aspetti clinici, diagnostici e terapeutici

Viallet, F., Gayraud, D., Bonnefoi, B., Renié, L., & Aurenty, R. (2010) · EMC - Neurologia · doi:10.1016/s1634-7072(10)70494-3

Smoking and PD in twins

Allam, M. F. (2002) · Neurology · doi:10.1212/wnl.59.11.1821-a

Does diet protect against Parkinson's disease? Part 4 – vitamins and minerals

Brown, I. (2004) · Nutrition & Food Science · doi:10.1108/00346650410560343

La cafeína en la enfermedad de Parkinson

Ferré, S. (2008) · Medicina Clínica · doi:10.1157/13129123

CoSIC – the Coffee Science Information Centre: who we are and what we provide

Cook, R. (2001) · Nutrition Bulletin · doi:10.1046/j.1467-3010.2001.00189.x

Coffee and tea for health?

O’Connell, N. (2008) · Nurse Prescribing · doi:10.12968/npre.2008.6.8.30762

3.146 MODULATION OF ADULT NEUROGENESIS IN THE OLFACTORY BULB IN AN ACUTE MOUSE MODEL OF PARKINSON'S DISEASE

Chiu, W., Carlsson, T., Arend, M., Höglinger, G. U., Oertel, W., & Ries, V. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70862-8

Mechanisms of aluminium neurotoxicity in oxidative stress-induced degenerative processes in relation to parkinson's disease

Iglesias, S. S. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Caffeine, Adenosine Receptors and Estrogen in Toxin Models of Parkinson's Disease

Schwarzschild, M. A. (2006) · Defense Technical Information Center (DTIC) · doi:10.21236/ada462198

Overview of Parkinson's Disease: Examing the role for the Gut-Brain-Gut axis and the use of Nutrients based on preclinical and clinical evidence

Koopman, H. J. M. (2013) · Utrecht University Repository (Utrecht University)

Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional

Cardoso, E. F. (2009) · Radiologia Brasileira · doi:10.1590/s0100-39842009000200017

Environmental Epidemiology of Sporadic Parkinson�s Disease

Chen, H., & Huang, X. (2010) · North American Journal of Medicine and Science · doi:10.7156/v3i1p073

Efeito de Estimulantes na Marcha e Postura Humana: Caso da cafeína

Cristina, M. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9b1b-9078

Neuroprotective Effect of Genistein : Studies in Rat Models of Parkinson’s and Alzheimer’s Disease

Bagheri, M. (2012) · DiVA (Linkoping University)

The design, synthesis and evaluation of aminocaffeine derivatives as inhibitors of monoamine oxidase B

Moraal, C. (2011)

Utilizing Galectin 3 as a Marker of Ruptured Vesicles In Vivo

London, J. (2015) · Loyola eCommons (Loyola University of Chicago)

Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder, Coffee Consumption and Mortality, Phytoestrogens for Menopause, Light Therapy for Non-Seasonal Depression, Electroacupuncture for Labor Pain

Mukherji, A., & Glickman-Simon, R. (2016) · EXPLORE · doi:10.1016/j.explore.2016.02.013

Efeito neuroprotetor da catequina e do estresse de imobilização subcrônico na doença de Parkinson experimental

Teixeira, M. D. A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

ENVIRONMENTAL PERSPECTIVES ENVIRONMENTAL PERSPECTIVES

Bronstein, J. M., Carvey, P. M., Chen, H., Cory‐Slechta, D. A., Monte, D. A. D., Duda, J. E., English, P. B., Goldman, S. M., Grate, S. J., Hansen, J., et al. (2008)

Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women

Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R. R., Freedman, N. D., Hollenbeck, A. R., Blair, A. E., & Chen, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr451 · Cited by 186

Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

Kim, I. Y., O’Reilly, É. J., Hughes, K. C., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171175 · Cited by 21

Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women

Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677

Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

Zhao, Y., Lai, Y., Konijnenberg, H., Huerta, J. M., Vinagre‐Aragón, A., Sabin, J., Hansen, J., Petrova, D., Sacerdote, C., Zamora‐Ros, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209201 · Cited by 49

Caffeine and risk of Parkinson’s disease in a large cohort of men and women

Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185